Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

Wirongrong ChierakulSiriluck AnunnatsiriWipada ChaowagulSharon J. PeacockPloenchan ChetchotisakdNicholas P. DayMahidol UniversityKhon Kaen UniversitySappasitthiprasong HospitalNuffield Department of Clinical Medicine2018-08-242018-08-242007-08-15Clinical Infectious Diseases. Vol.45, No.4 (2007), 521-523105848382-s2.0-34547647816https://repository.li.mahidol.ac.th/handle/123456789/24784Mahidol UniversityMedicineAddition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]LetterSCOPUS10.1086/520011